Rhythm Pharmaceuticals, Inc. (RYTM) Net Income by Year
Rhythm Pharmaceuticals, Inc. reported a net loss of $197K in fiscal year 2025. This represents an increase of 24.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $9.0M net loss. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Rhythm Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RYTM Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
RYTM Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Rhythm Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Rhythm Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Rhythm Pharmaceuticals, Inc. reported a net loss of $197K in fiscal year 2025.
How fast is Rhythm Pharmaceuticals, Inc.'s net income growing?
Rhythm Pharmaceuticals, Inc. (RYTM) net income rose by 24.6% year over year, from -$261K to -$197K in fiscal year 2025.
What is Rhythm Pharmaceuticals, Inc.'s net income over the last twelve months?
Rhythm Pharmaceuticals, Inc. (RYTM) reported a $9.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Rhythm Pharmaceuticals, Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, Rhythm Pharmaceuticals, Inc. (RYTM) net income went from -$11.1M in fiscal year 2015 to -$197K in fiscal year 2025.
What was Rhythm Pharmaceuticals, Inc.'s net income in the most recent quarter?
Rhythm Pharmaceuticals, Inc. (RYTM) reported -$49.3M in net income in Q2 2026. This represents a decrease of 5.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Rhythm Pharmaceuticals, Inc. (RYTM) reported on that line in every period on record.